Skip to main content
. Author manuscript; available in PMC: 2015 Sep 30.
Published in final edited form as: Gynecol Oncol. 2011 Mar 12;121(3):595–599. doi: 10.1016/j.ygyno.2011.02.005

Table 2.

Predictors of vulvar cancer-specific mortality.

Hazard ratio (95% CI) p-value
Age at diagnosis-category 0.0046
 65–74 years olda 1.0
 75–84 years old 0.38 (0.18, 0.84)
 85+ years old 1.79 (0.78, 4.09)
Stage 0.0009
 Ia 1.0
 II 0.85 (0.31, 2.34)
 III 0.62 (0.20, 1.94)
 IV 3.17 (1.14, 8.80)
Lymph node involvement < 0.0001
 Nonea 1.0
 Lymph node involvement 7.47 (3.09, 18.04)
Surgery performed < 0.0001
 Radical vulvectomy onlya 1.0
 Local excision only 3.77 (0.75, 18.85)
 Unilateral or bilateral inguinal LND 12.77 (2.52, 64.64)
 Radical vulvectomy + inguinal LND 2.08 (0.49, 8.83)
Adjuvant therapy <0.0001
 Nonea 1.0
 Chemo or radiation therapy only 59.86 (19.21,186.54)
 Chemo and radiation therapy 0.84 (0.36, 2.00)
a

Reference group.